168 related articles for article (PubMed ID: 7974738)
1. Diagnostic utility of whole blood cyclosporine measurements in renal transplantation using triple therapy.
Nankivell BJ; Hibbins M; Chapman JR
Transplantation; 1994 Nov; 58(9):989-96. PubMed ID: 7974738
[TBL] [Abstract][Full Text] [Related]
2. [Blood levels of cyclosporine, acute rejections and the prognosis of the allografts in pediatric renal allograft recipients].
Sakuma T; Ogawa O; Kawamura T; Hasegawa A; Kamidono S
Nihon Hinyokika Gakkai Zasshi; 1995 Sep; 86(9):1450-9. PubMed ID: 7474634
[TBL] [Abstract][Full Text] [Related]
3. Cyclosporine trough concentrations in predicting allograft rejection and renal toxicity up to 12 months after renal transplantation.
Min DI; Perry PJ; Chen HY; Hunsicker LG
Pharmacotherapy; 1998; 18(2):282-7. PubMed ID: 9545147
[TBL] [Abstract][Full Text] [Related]
4. Triple therapy in cadaveric renal transplantation: role of induction cyclosporine and targeted levels to avoid rejection.
Khauli RB; Wilson JM; Baker SP; Valliere SA; Lovewell TD; Stoff JS
J Urol; 1995 Jun; 153(6):1805-9; discussion 1810. PubMed ID: 7752322
[TBL] [Abstract][Full Text] [Related]
5. Smooth muscle-specific actin levels in the urine of renal transplant recipients: correlation with cyclosporine or tacrolimus nephrotoxicity.
Haas M; Meehan SM; Josephson MA; Wit EJ; Woodle ES; Thistlethwaite JR
Am J Kidney Dis; 1999 Jul; 34(1):69-84. PubMed ID: 10401019
[TBL] [Abstract][Full Text] [Related]
6. Expression of multidrug resistance P-glycoprotein in kidney allografts from cyclosporine A-treated patients.
Koziolek MJ; Riess R; Geiger H; Thévenod F; Hauser IA
Kidney Int; 2001 Jul; 60(1):156-66. PubMed ID: 11422747
[TBL] [Abstract][Full Text] [Related]
7. Effect of early cyclosporine levels on kidney allograft rejection.
Johnson EM; Canafax DM; Gillingham KJ; Humar A; Pandian K; Kerr SR; Najarian JS; Matas AJ
Clin Transplant; 1997 Dec; 11(6):552-7. PubMed ID: 9408683
[TBL] [Abstract][Full Text] [Related]
8. Cyclosporine plasma levels in renal transplant patients. Association with renal toxicity and allograft rejection.
Klintmalm G; Säwe J; Ringdén O; von Bahr C; Magnusson A
Transplantation; 1985 Feb; 39(2):132-7. PubMed ID: 3881851
[TBL] [Abstract][Full Text] [Related]
9. A prospective study of cyclosporine concentration in relation to its therapeutic effect and toxicity after renal transplantation.
Lindholm A; Dahlqvist R; Groth GG; Sjöqvist F
Br J Clin Pharmacol; 1990 Sep; 30(3):443-52. PubMed ID: 2223423
[TBL] [Abstract][Full Text] [Related]
10. Improved renal function in sirolimus-treated renal transplant patients after early cyclosporine elimination.
Gonwa TA; Hricik DE; Brinker K; Grinyo JM; Schena FP;
Transplantation; 2002 Dec; 74(11):1560-7. PubMed ID: 12490789
[TBL] [Abstract][Full Text] [Related]
11. Modifying cyclosporine associated renal allograft dysfunction.
Mohapatra N; Vanikar AV; Patel RD; Trivedi HL
Saudi J Kidney Dis Transpl; 2009 Sep; 20(5):770-4. PubMed ID: 19736471
[TBL] [Abstract][Full Text] [Related]
12. Absorption profiling of cyclosporine microemulsion (neoral) during the first 2 weeks after renal transplantation.
Canadian Neoral Renal Transplantation Study Group
Transplantation; 2001 Sep; 72(6):1024-32. PubMed ID: 11579295
[TBL] [Abstract][Full Text] [Related]
13. [Nephrotoxicity of cyclosporin A after kidney transplantation].
Rainiene T; Papinigiene L; Laurinavicius A
Medicina (Kaunas); 2003; 39 Suppl 1():161-5. PubMed ID: 12761440
[TBL] [Abstract][Full Text] [Related]
14. In renal transplantation blood cyclosporine levels soon after surgery act as a major determinant of rejection: insights from the MY.S.S. trial.
Perico N; Ruggenenti P; Gotti E; Gaspari F; Cattaneo D; Valente U; Salvadori M; Segoloni G; Donati D; Sandrini S; Ganeva M; Dimitrov BD; Remuzzi G;
Kidney Int; 2004 Mar; 65(3):1084-90. PubMed ID: 14871429
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic contribution of renal allograft biopsies at various intervals after transplantation.
Kon SP; Templar J; Dodd SM; Rudge CJ; Raftery MJ
Transplantation; 1997 Feb; 63(4):547-50. PubMed ID: 9047149
[TBL] [Abstract][Full Text] [Related]
16. Granulysin expression is a marker for acute rejection and steroid resistance in human renal transplantation.
Sarwal MM; Jani A; Chang S; Huie P; Wang Z; Salvatierra O; Clayberger C; Sibley R; Krensky AM; Pavlakis M
Hum Immunol; 2001 Jan; 62(1):21-31. PubMed ID: 11165712
[TBL] [Abstract][Full Text] [Related]
17. Clinical correlations of cyclosporine-specific and -nonspecific assays in stable renal transplants, acute rejection, and cyclosporine nephrotoxicity.
Schroeder TJ; Sridhar N; Pesce AJ; Alexander JW; First MR
Ther Drug Monit; 1993 Jun; 15(3):190-4. PubMed ID: 8332997
[TBL] [Abstract][Full Text] [Related]
18. Serum cyclosporine kinetic profile. Failure to correlate with nephrotoxicity or rejection episodes following sequential immunotherapy for renal transplantation.
Sommer BG; Sing DE; Henry ML; Ferguson RM; Orosz CG
Transplantation; 1988 Jan; 45(1):86-90. PubMed ID: 3276069
[TBL] [Abstract][Full Text] [Related]
19. Expression of adhesion molecules in allograft renal dysfunction. A distinct diagnostic pattern in rejection and cyclosporine nephrotoxicity.
Mampaso F; Sanchez-Madrid F; Marcen R; Molina A; Pascual J; Bricio T; Martin A; Alvarez V
Transplantation; 1993 Sep; 56(3):687-91. PubMed ID: 8212167
[TBL] [Abstract][Full Text] [Related]
20. Increased renal tubular expression of transforming growth factor beta in human allografts correlates with cyclosporine toxicity.
Pankewycz OG; Miao L; Isaacs R; Guan J; Pruett T; Haussmann G; Sturgill BC
Kidney Int; 1996 Nov; 50(5):1634-40. PubMed ID: 8914030
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
